Signettx
1 known investors
Signet Therapeutics develops targeted cancer drugs using cancer organoid models combined with artificial intelligence. The company focuses on discovering novel therapies for cancers that currently lack effective treatment options.
Investors · 1
Frequently asked questions
- What does Signettx do?
- Signet Therapeutics develops targeted cancer drugs using cancer organoid models combined with artificial intelligence. The company focuses on discovering novel therapies for cancers that currently lack effective treatment options.
- Who are Signettx's investors?
- Signettx's investors include Blue Ocean Capital Group.